Skip to content

Nordic Long-term Obsessive compulsive disorder (OCD) Treatment Study

Nordic Long-term Obsessive compulsive disorder (OCD) Treatment Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN66385119
Enrollment
300
Registered
2008-03-19
Start date
2008-01-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive compulsive disorder Mental and Behavioural Disorders Obsessive compulsive disorder

Interventions

Step 1: Cognitive behaviour therapy (CBT) Step 2: Sertraline plus CBT support (less intensive CBT) or intensive CBT Step 3: Sertraline plus CBT support plus aripiprazol Non-responders to CBT are rand

Sponsors

The Centre for Child and Adolescent Mental Health, Eastern and Southern Norway (R.BUP) (Norway)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients 7 - 17 years of age 2. Moderate-severe obsessive compulsive disorder according to Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM IV). Severity is defined by Children's Yale-Brown Obsessive Compulsive Scales (CY-BOCS) scores of 16 or above

Exclusion criteria

Exclusion criteria: 1. Co-morbidity has not higher treatment priority (e.g. psychosis, anorexia nervosa, severe depression with suicidality, an autistic disorder or Asperger's syndrome) 2. Pervasive developmental disorders (PDD) not otherwise specified (NOS) is allowed if Clinical Global Impression (CGI) score for the PDD is less than or equal to 3 and CGI for the PDD NOS is less than or equal to CGI for the OCD 3. Mental retardation (intelligence quotient [IQ] less than 70) 4. Patients have not been treated with selective serotonin reuptake inhibitor (SSRI) or CBT for their OCD during the last year 5. If the patient is of non-Nordic ethnicity both the patient and one parent must speak a Nordic language

Design outcomes

Primary

MeasureTime frame
1. CYBOCS 2. Clinical Global Impression Scale 3. Clinical Global Improvement Scale 4. Children's OCD Impact Scale Outcomes measured (approximately) at weeks 0, 7, 13, and months 6, 12, 24, 36.

Secondary

MeasureTime frame
1. Screen for Child Anxiety Related Disorders Revised (SCARED-R) 2. Mood and Feelings Questionnaire (MFQ) 3. Children's Global Assessment Scale (CGAS) 4. Child Behaviour Checklist (CBCL) 5. Family Accomodation Scale (FAS) 6. Need to add another treatment Outcomes measured (approximately) at weeks 0, 7, 13, and months 6, 12, 24, 36.

Countries

Denmark, Norway, Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 11, 2026